FI850618L - 2-oxo-1,2,3,5-tetrahydroimidazo/2,1-b/ kinazolinyl)oxialkylamider. - Google Patents

2-oxo-1,2,3,5-tetrahydroimidazo/2,1-b/ kinazolinyl)oxialkylamider.

Info

Publication number
FI850618L
FI850618L FI850618A FI850618A FI850618L FI 850618 L FI850618 L FI 850618L FI 850618 A FI850618 A FI 850618A FI 850618 A FI850618 A FI 850618A FI 850618 L FI850618 L FI 850618L
Authority
FI
Finland
Prior art keywords
oxialkylamider
tetrahydroimidazo
quinazolinyl
oxo
Prior art date
Application number
FI850618A
Other languages
English (en)
Other versions
FI850618A0 (fi
FI81578C (fi
FI81578B (fi
Inventor
John H Fried
Michael C Venuti
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI850618A0 publication Critical patent/FI850618A0/fi
Publication of FI850618L publication Critical patent/FI850618L/fi
Application granted granted Critical
Publication of FI81578B publication Critical patent/FI81578B/fi
Publication of FI81578C publication Critical patent/FI81578C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI850618A 1984-02-15 1985-02-14 Foerfarande foer framstaellning av nya fosfodiesterasinhibierande 1,2,3,5-tetrahydroimidazo/2,1-b/ kinazolinderivat. FI81578C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58040984A 1984-02-15 1984-02-15
US58040984 1984-02-15

Publications (4)

Publication Number Publication Date
FI850618A0 FI850618A0 (fi) 1985-02-14
FI850618L true FI850618L (fi) 1985-08-16
FI81578B FI81578B (fi) 1990-07-31
FI81578C FI81578C (fi) 1990-11-12

Family

ID=24320992

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850618A FI81578C (fi) 1984-02-15 1985-02-14 Foerfarande foer framstaellning av nya fosfodiesterasinhibierande 1,2,3,5-tetrahydroimidazo/2,1-b/ kinazolinderivat.

Country Status (13)

Country Link
US (1) US4690925A (fi)
EP (1) EP0153152A3 (fi)
JP (1) JPS60193991A (fi)
AU (1) AU581205B2 (fi)
CA (1) CA1254557A (fi)
DK (1) DK69285A (fi)
ES (2) ES8607299A1 (fi)
FI (1) FI81578C (fi)
HU (2) HU191316B (fi)
IL (1) IL74349A (fi)
NO (1) NO164654C (fi)
NZ (1) NZ211117A (fi)
ZA (1) ZA851131B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
IL74349A (en) * 1984-02-15 1988-07-31 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolinyl)-oxyalkylamides,their preparation and pharmaceutical compositions containing them
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
ATE141791T1 (de) 1991-07-05 1996-09-15 Byk Gulden Lomberg Chem Fab Verwendung substituierter pyridazine gegen dermatosen
EP0597956A1 (en) * 1991-07-29 1994-05-25 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31617A (en) * 1861-03-05 photo-uthcqfupheh
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
USRE31617E (en) 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4313947A (en) * 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
JPS54163825A (en) * 1978-06-15 1979-12-26 Otsuka Pharma Co Ltd Phosphoesterase inhibitor
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4551459A (en) * 1983-02-16 1985-11-05 Syntex (U.S.A.) Inc. Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
IL74349A (en) * 1984-02-15 1988-07-31 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolinyl)-oxyalkylamides,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU191316B (en) 1987-02-27
US4690925A (en) 1987-09-01
DK69285D0 (da) 1985-02-14
HU193409B (en) 1987-10-28
ES8606297A1 (es) 1986-04-16
ES549920A0 (es) 1986-04-16
FI850618A0 (fi) 1985-02-14
EP0153152A2 (en) 1985-08-28
EP0153152A3 (en) 1987-07-15
ZA851131B (en) 1986-09-24
FI81578C (fi) 1990-11-12
FI81578B (fi) 1990-07-31
AU3875485A (en) 1985-08-22
NZ211117A (en) 1987-10-30
ES540403A0 (es) 1986-06-01
HUT36122A (en) 1985-08-28
DK69285A (da) 1985-08-16
IL74349A (en) 1988-07-31
JPS60193991A (ja) 1985-10-02
NO850564L (no) 1985-08-16
NO164654B (no) 1990-07-23
CA1254557A (en) 1989-05-23
IL74349A0 (en) 1985-05-31
AU581205B2 (en) 1989-02-16
NO164654C (no) 1990-10-31
ES8607299A1 (es) 1986-06-01

Similar Documents

Publication Publication Date Title
FI851114A0 (fi) Lagringsstabila, snabbt soederfallande farmaceutiska aktivaemnespresstycken.
FI850993A0 (fi) Utryckningsfordon, speciellt tankslaeckningsfordon foer flygfaelt.
FI851937A0 (fi) Utryckningsfordon, saerskilt brandbil.
FI851505A0 (fi) Valsanordning, speciellt foer en kalander.
FI841948A0 (fi) Kanna, speciellt termoskanna.
FI852196A0 (fi) Mjukgoerande, builderaemnehaltig tvaettmedelskomposition.
FI850618L (fi) 2-oxo-1,2,3,5-tetrahydroimidazo/2,1-b/ kinazolinyl)oxialkylamider.
FI852087A0 (fi) Glidytsbelaeggning foer skida, speciellt terraengskida.
FI851383L (fi) Polyfosfat innehaollande, flytande tvaettmedelskomposition foer tvaettinraettningar.
FI851935L (fi) Utryckningsfordon, saosom brandbil.
FI840878A (fi) Ventilations-/vaermevaexlarsystem foer djurskydd, saerskilt broilerhoenshus.
FI852088A0 (fi) Enhetliga, styva, fristaoende, gasgenomslaeppliga, laogtemperaturbundna sandkornsformar.
FI851743A0 (fi) Saekerhetsfoerslutningskork, saerskilt foer flaskor foer farmaceutiskt bruk.
FI851206L (fi) Isoleringskaerl, saerskilt termoskanna.
FI843996A0 (fi) Kluvet braensle-element foer kaernreaktor, isynnerhet foer kokvattenreaktor.
FI853032A0 (fi) Foerberedd installationsenhet, saerskilt sanitetsenhet.
FI850923L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara /(2-hydroxi-fenyl)metylenamino/ fenylalkankarboxylsyraderivat.
FI851980L (fi) Behaollare foer livsmedel, saerskilt soetsaker, anvaendbar saosom sparboessa.
FI853297A0 (fi) Kokanordning, foeretraedesvis grillanordning.
IE850358L (en) (2-OXO-1, 2, 3, 5-TETRAHYDROIMIDAZO (2,1-b) QUINAZOLINYL)¹OXYALKYLAMIDES.
FI883773A0 (fi) Foerfarande foer framstaellning av (1-fenyletyl) hydrokinon.
IT8419415A0 (it) Composti 5, 6, 7,8-tetraidroimidazopiridinici.
FI851408A0 (fi) Backslagsventil, speciellt skivbackslagsventil.
FI841205A0 (fi) Planerings-, konstruerings- och styrningsfoerfarande foer anrikningsverk, speciellt foer malningsapparature malningsapparaturer.
FI841778A0 (fi) Tvaettvante, saerskilt foer sjukhusbruk.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTEX (U.S.A.) INC.